Lantern Pharma Inc (NAS:LTRN)
$ 3.27 -0.01 (-0.3%) Market Cap: 35.20 Mil Enterprise Value: 2.27 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 39/100

Q4 2022 Lantern Pharma Inc Earnings Call Transcript

Mar 20, 2023 / 08:30PM GMT
Release Date Price: $4.65 (-2.11%)
Nicole Leber
Lantern Pharma Inc. - IR Associate

Good afternoon, everyone. I'm Nicole Leber with Investor Relations here at Lantern Pharma, and welcome to our fourth-quarter and full-year 2022 earnings call. I will be your host for today's call.

As a reminder, this call is being recorded and all attendees are in a listen-only mode. We will open up the call for questions and answers after management's presentation. A webcast replay of today's conference call will be available on our website at lanternpharma.com after the call.

We issued a press release after market close today summarizing our financial results and progress across the company for the fourth quarter and full year of 2022. A copy of this release is available through our website at lanternpharma.com, where you will also find a link to the slides that management will be referencing on today's call.

I would like to remind everyone that remarks about future expectations, performance, estimates, and prospects constitute forward-looking statements for purposes of Safe Harbor provisions under the Private Securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot